首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1374798

全球心電圖貼片與動態心電圖監測儀市場 -2023-2030

Global ECG Patches and Holter Monitor Market -2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

動態監測設備的趨勢、該領域的技術進步、心律不整早期檢測投資的增加以及遙測領域的進步將有助於市場在預測期內成長。心電圖貼片是一種連接到體表（通常是胸部）的小型設備，用於處理、擷取和傳輸患者心臟活動的電訊號。

監視器中顯示的資訊隨後用於醫療診斷（動態心電圖監視器）或用於顯示健身活動中的心率等參數。如果傳統心電圖（ECG 或 EKG）無法提供有關心臟狀況的足夠詳細資訊，則可以進行動態心電圖監測測試。如果不規則心跳不頻繁，則可能需要稱為事件記錄器的長期監測器。

此外，全球心電圖心律不整的盛行率不斷上升、主要參與者推出新設備、與公司的併購、對動態監測設備的需求不斷增加以及技術進步可能會在預測期內推動市場發展，並具有重要的關鍵角色諸如 Cardinal Health、Ambu、Hillrom (Baxter)、Nihon Kohden、Koninklijke Philips NV 等廠商。

動力學

心房顫動盛行率上升

心房顫動盛行率的上升是預測期內幫助市場成長的關鍵因素之一。普及率的提高將導致對心電圖貼片和動態心電圖監測設備的高需求。

例如，根據 NCBI 上發表的一篇最新文章，心房顫動是最常見的心律不整。心房顫動的盛行率在全世界不斷增加。眾所周知，心房顫動的盛行率通常隨著年齡的成長而增加。據估計，到 2050 年，患有心房顫動的人數將增加一倍或三倍。

儘管全球心房顫動的盛行率約為 1%，但 75 歲以上的人中約有 9% 患有心房顫動。80 歲時，一生中罹患心房顫動的風險躍升至 22%。此外，心房顫動更常見於男性，且與黑人相比，在白人中更常見。

科技進步的崛起

技術進步的崛起是預測期內幫助市場成長的關鍵因素之一。該市場的進步之一是黏性單導聯設備在過去 20 年中不斷出現，作為一種改進的心電圖遠端監測方法。憑藉其不那麼突兀的設計和長達 14 天的佩戴時間，這些生物感測器「貼片」技術已被證明在診斷心律不整方面優於動態心電圖監測儀。 iRhythm (Zio) 的 ZIO 是用於檢測心律不整的連續動態監測貼片技術的一個例子。此外，動態心電圖技術已經發展了許多技術，該技術將有助於市場在預測期內的成長。

例如，2020 年 11 月，Vital Connect 宣布推出 VitalPatch RTM，這是第一個用於心臟監測的擴展動態心電圖技術。 Vital Connect 推出了最新的心臟監測貼片 VitalPatch RTM，適合需要擴展動態心電圖監測的患者。這款穿戴式生物感測器透過使用人工智慧心電圖感測器來尋找 21 種不同的心律不整。它持續監測四個重要的生命徵象：心率、心率變異性、呼吸頻率和活動。

繁瑣且過時的動態心電圖分析

傳統的動態心電圖分析由心臟科醫生手動進行，非常複雜並且需要大量的努力。進行動態心電圖檢查時，護理師必須將動態心電圖設備的原始訊號上傳到電腦，然後醫生根據他們目前的知識和經驗創建報告。因此，醫生需要經驗豐富、精確且警惕，才能正確準備這樣的報告。

The trend towards ambulatory monitoring devices, technological advancements in the field, increase in investments for early detection of arrhythmia, and advancements in the field of telemetry will help the market to grow during the forecast period. The ECG patch is a small device that is connected to the body surface (commonly the chest) to process, acquire and transmit the electrical signal of the patient's heart activity.

The information which was shown in monitor is later used for medical diagnostics (Holter monitors) or for displaying parameters such as heart rate in fitness activities. A Holter monitor test may be done if a traditional electrocardiogram (ECG or EKG) doesn't provide enough details about the heart's condition. If the irregular heartbeats are infrequent, a longer-term monitor called an event recorder may be needed.

Furthermore, the global ECG The Growing prevalence of cardiac arrhythmia, new device launches by key players, mergers and acquisitions with the companies, increasing demand for ambulatory monitoring devices, and technological advancements are likely to drive the market during the forecast period with having significant key players like Cardinal Health, Ambu, Hillrom (Baxter), Nihon Kohden, Koninklijke Philips N.V and others.

Dynamics

Rise in the Prevalence of Atrial Fibrillation

The rise in the prevalence of atrial fibrillation is one of the key factors that help the market to grow during the forecast period. Increase the prevalence will lead to high demand for ECG Patches and Holter monitor devices.

For instance, according to an updated article published in NCBI Atrial fibrillation is the most commonly encountered cardiac rhythm disorder. The prevalence of atrial fibrillation has been increasing worldwide. It is known that the prevalence of atrial fibrillation generally increases with age. It has been estimated that the number of individuals with atrial fibrillation will double or triple by the year 2050.

Although the worldwide prevalence of atrial fibrillation is approximately 1%, it is found in approximately 9% of individuals over the age of 75. At the age of 80, the lifetime risk of developing atrial fibrillation jumps to 22%. In addition, atrial fibrillation has more commonly been associated with males and is seen more often in whites as compared to blacks.

Rise in the Technological Advancements

The rise in the technological advancements is one of the key factors that helps the market to grow during the forecast period. One of the advancements in this market was Adhesive single-lead devices have been emerging over the last 20 years as an improved method of ECG remote monitoring. With their less obtrusive design and wear time of up to 14 days, these biosensor 'patch' technologies have been shown to outperform Holter monitors in diagnosing cardiac arrhythmias. ZIO by iRhythm (Zio) is an example of a continuous ambulatory monitoring patch technology used to detect cardiac arrhythmias. Also, numerous technologies have been evolved in Holter Technology and this technology will help the market to grow during the forecast period.

For instance, in November 2020 Vital Connect announced the Launch of VitalPatch RTM, a first-of-its-kind extended holter technology for cardiac monitoring. Vital Connect has launched its latest cardiac monitoring patch, the VitalPatch RTM, for patients who require extended Holter monitoring. The wearable biosensor looks for 21 different cardiac arrhythmias by using an artificial intelligence electrocardiogram sensor. It continuously monitors four significant vital signs: heart rate, heart rate variability, respiratory rate and activity.

Tedious And Outdated Holter ECG Analysis

Traditional Holter ECG analysis conducted manually by a cardiologist is complicated and requires a lot of effort. When a Holter examination is carried out, the nurse has to upload the raw signal from the Holter device to a computer, and then the physician creates their report, based on their current knowledge and experience. Thus, the doctor needs to be experienced, precise, and vigilant to be able to prepare such a report correctly.

Segment Analysis

The global ECG Patches and Holter Monitor market is segmented based on device type, application, end-user and region.

The ECG Patches Segment From the Device Type Segment Accounted For Approximately 41.7% of ECG Patches and Holter Monitor Share

The ECG Patches segment from the device type segment accounted for 41.7% and it is expected to be dominated during the forecast period. A wearable ECG patch is equipped with an electrocardiography sensor and accelerometer to detect and record physiological data. Similar to smartwatches, ECG patches can be synced with a device such as a phone or a tablet to display the results.

For instance, in May 2023, VTT Technical Research Centre of Finland developed a new sustainable electrocardiogram (ECG, also known as EKG) patch that is fully recyclable and made of biomaterials. The device is modular, so electronic components can be easily removed from the disposable patch and used again.

The patch itself is made of nanocellulose and printed with carbon conductors and sensing electrodes. The biodegradable patch is made of VTT's new material cellulose e-skin, which replaces traditional plastic in wearable skin applications.

Furthermore, in August 2022 SmartCardia, a leading MedTech company dedicated to strengthening the healthcare ecosystem, launched 7L patch, their 7-lead Cardiac Monitoring Patch in India. This state-of-the-art patch monitor combines medical wearable technology with AI to provide predictive and personalized patient insights through remote monitoring. The 7L patch is tracked by SmartCardia's AI platform which is developed from millions of ECG segments interpreted by cardiologists and certified cardiac technicians and performs real-time detection of important arrhythmia events at cardiologist level accuracy.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the rising incidence of Atrial Fibrillation in the region, ageing population, technological advancements, mergers and acquisitions, shifting patient preference toward ambulatory ECG monitoring, the launch of next-generation wireless ECG monitoring devices, and technological collaborations between manufacturers.

For instance, in January 2021, Boston Scientific announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors - including short and long-term Holter monitors - to cardiac event monitors and mobile cardiac telemetry. The transaction consists of an upfront cash payment of $925 million, and up to an additional $300 million in a potential commercial milestone payment.

Competitive Landscape

The major global players in the market include: Cardinal Health, Ambu, Hillrom (Baxter), Nihon Kohden, Koninklijke Philips N.V., Koninklijke Philips N.V., SCHILLER, GE Healthcare, Henry Schein, Spacelabs Healthcare and among others.

COVID-19 Impact Analysis

COVID-19 has positively impacted the market by increasing the use of ECG patches and Holter monitor devices for diagnosing, evaluating, and treating cardiac conditions. Patients with rhythm monitoring therapy are at a higher risk of developing severe diseases, leading to increased demand and growth in the market.

Also, the COVID-19 pandemic has resulted in high burden on public health and healthcare delivery globally. The disease has major effects on the cardiovascular system. A wide range of arrhythmias have been reported in patients, which complicate the course of COVID-19 due to the associated treatments.

Key Developments

In May 2023 Vivalink, a leading provider of digital healthcare solutions, stated the newest version of its multi-parameter wearable electrocardiogram (ECG) patch with continuous 14-day live stream capabilities. With Vivalink's new patch, extended duration remote ECG monitoring can be performed with a single application of the patch, thereby reducing both clinician and patient burden. In addition, the real-time streaming capabilities let clinicians remotely view a patient's live ECG anywhere anytime.
In October 2022 Dozee, a healthcare startup that provides contactless remote patient- monitoring launched an easy-to-use ambulatory electrocardiogram (ECG) patch to monitor patients with cardiovascular disease (CVD). This ECG patch is to augment and play a key role in assisting health care professionals (HCPs) in identifying early signs of cardiac deterioration ensuring there is timely medical intervention, thereby improving patient safety.
In April 2022 B-Secur stated the launch of the FDA-cleared next-generation ECG cloud-based platform for use across Holter monitors, wearables and implantable devices. According to a company press release, the cloud-based software (Heart Key 2.0) reduces ECG signal noise, improving ECG interpretation for clinicians and facilitating the trend towards remote cardiac monitoring.

Why Purchase the Report?

To visualize the global ECG Patches and Holter Monitor market segmentation based on device type, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global ECG Patches and Holter Monitor market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global ECG patches and Holter monitor market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Device Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Prevalence of Atrial Fibrillation
  - 4.1.1.2. Rise in the Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Tedious And Outdated Holter ECG Analysis
- 4.1.3. Opportunity
  - 4.1.3.1. Rise in the Product Launches in Emerging Markets
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Device Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 7.1.2. Market Attractiveness Index, By Device Type
7.2. ECG Patches*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Holter Monitor

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Monitoring *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diagnostics

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Specialty Clinics
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Cardinal Health*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Ambu
12.3. Hillrom (Baxter)
12.4. Nihon Kohden
12.5. Koninklijke Philips N.V.
12.6. Koninklijke Philips N.V.
12.7. SCHILLER
12.8. GE Healthcare
12.9. Henry Schein
12.10. Spacelabs Healthcare

LIST NOT EXHAUSTIVE